- Home
- OLP vs LYEL Comparison
OLP vs LYEL Comparison
Compare OLP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | LYEL |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 490.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OLP | LYEL |
|---|---|---|
| Price | $23.09 | $25.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 50.0K | ★ 91.2K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $82,740,000.00 | $61,000.00 |
| Revenue This Year | $8.03 | N/A |
| Revenue Next Year | $7.26 | N/A |
| P/E Ratio | $22.52 | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $19.62 | $0.39 |
| 52 Week High | $27.69 | $45.00 |
Technical Indicators
Market Signals| Indicator | OLP | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 55.64 |
| Support Level | $22.67 | $21.27 |
| Resistance Level | $23.31 | $27.30 |
| Average True Range (ATR) | 0.56 | 1.78 |
| MACD | -0.09 | 0.32 |
| Stochastic Oscillator | 48.07 | 73.27 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.